We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$37.9M
2
BX icon
Blackstone
BX
+$16.9M
3
ABNB icon
Airbnb
ABNB
+$13.4M
4
KVUE icon
Kenvue
KVUE
+$10.4M
5
CIVI
Civitas Resources
CIVI
+$7.3M

Top Sells

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$125M
2
ACN icon
Accenture
ACN
+$57.6M
3
MDT icon
Medtronic
MDT
+$28M
4
AAPL icon
Apple
AAPL
+$21.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$19.3M

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPTA
2701
Perpetua Resources
PPTA
$3.08B
$70.2K ﹤0.01%
21,541
– –
GWRS icon
2702
Global Water Resources
GWRS
$242M
$70.1K ﹤0.01%
7,188
– –
TG icon
2703
Tredegar Corp
TG
$276M
$69.6K ﹤0.01%
12,857
– –
RELL icon
2704
Richardson Electronics
RELL
$302M
$69.5K ﹤0.01%
6,360
– –
FCCO icon
2705
First Community Corp
FCCO
$325M
$69.5K ﹤0.01%
4,022
– –
SEER icon
2706
Seer Inc
SEER
$116M
$69.3K ﹤0.01%
31,352
– –
MACK
2707
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$69.2K ﹤0.01%
5,610
– –
EGAN icon
2708
eGain
EGAN
$198M
$68.9K ﹤0.01%
11,241
– –
SPB icon
2709
Spectrum Brands
SPB
$2.07B
$68.6K ﹤0.01%
875
+1
+0.1% +$79
ALT icon
2710
Altimmune
ALT
$558M
$68.4K ﹤0.01%
26,315
– –
SBT
2711
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$68.4K ﹤0.01%
+11,706
New +$68.5K
DHX icon
2712
DHI Group
DHX
$171M
$68.3K ﹤0.01%
22,332
– –
NWL icon
2713
Newell Brands
NWL
$2.66B
$68.1K ﹤0.01%
7,543
-88,166
-92% -$877K
RRGB icon
2714
Red Robin
RRGB
$187M
$68.1K ﹤0.01%
8,467
– –
TELA icon
2715
TELA Bio
TELA
$33.8M
$67.7K ﹤0.01%
8,467
– –
BH icon
2716
Biglari Holdings Class B
BH
$1.23B
$67.6K ﹤0.01%
407
– –
STKS icon
2717
The ONE Group
STKS
$56.8M
$67.4K ﹤0.01%
12,255
– –
LAZ icon
2718
Lazard
LAZ
$4.28B
$67.3K ﹤0.01%
2,170
+3
+0.1% +$101
MLYS icon
2719
Mineralys Therapeutics
MLYS
$2.34B
$67.2K ﹤0.01%
7,063
– –
SMTI icon
2720
Sanara MedTech
SMTI
$315M
$66.8K ﹤0.01%
2,147
– –
RNAC icon
2721
Cartesian Therapeutics
RNAC
$267M
$65.9K ﹤0.01%
2,073
– –
AAP icon
2722
Advance Auto Parts
AAP
$3.36B
$65.8K ﹤0.01%
1,177
-13,903
-92% -$931K
DNA icon
2723
Ginkgo Bioworks
DNA
$486M
$65.6K ﹤0.01%
907
+2
+0.2% +$160
INNV icon
2724
InnovAge Holding
INNV
$1.45B
$65.1K ﹤0.01%
10,873
– –
INGN icon
2725
Inogen
INGN
$154M
$65.1K ﹤0.01%
12,466
– –
107 108
109
110 111

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.